Regenerative Medicine Market information,
By Material (Synthetic Materials, Genetically Engineered Materials,
Pharmaceuticals), By Therapy (Stem Cell Biology, Cellular Therapy, Tissue
Engineering), By Application (Cord Blood, Oncology, Urology, Orthopedics,
Neurology, Dermatology) - Forecast till 2022
Market Scenario:
The Global
Regenerative Medicine Market is growing steadily. Factors that influence the
regenerative medicine market are increasing advancement in healthcare
technology, increasing advance technology in regenerative medicine market,
increasing prevalence of chronic diseases, increasing growth in stem cell
technology and others. Globally the market for regenerative medicine is
expected to grow at the rate of about 25.4% from 2016 to 2022.
Investments are likely to flow towards
the regenerative
medicine market over the next couple of years. In addition, the support extended by the government for drug
development is poised to revolutionize the future trajectory of the global
market. It is also likely to benefit from technological advancements in the
market.
Stem cell technology is gaining
traction in the healthcare sector. Its accelerated adoption in the field of
medical science is also anticipated to have a favorable impact on the expansion
of the regenerative medicine market. The players of the market are forecasted
to capitalize on the gap prevailing between the demand and supply for organs.
However, factors such as stringent regulations, and the high cost of the treatment are expected to check the proliferation
of the regenerative medicine market through the projection period.
Market
Segmentation:
on the basis of material, the regenerative medicine
market has been segmented into synthetic
materials, genetically engineered materials, pharmaceuticals, biologically
derived materials, and others.
On the basis of therapy, the global regenerative
medicine market has been segmented into
stem cell biology, cellular therapy, tissue engineering, and others.
On the basis of application, the regenerative
medicine market has been segmented into
cord blood, oncology, urology, orthopedics, neurology, dermatology,
cardiovascular, orthopedic and others.
Competitive
Dashboard:
Some of the key
players profiled in the report are
Cook Biotech, Organogenesis, Stryker and RTI surgical, Baxter International,
Inc., Osiris Therapeutics, CryoLife, Sanofi, LifeSciences, Advanced Cell
Technology, BioMimetic Therapeutics, LifeCell Kinetic Concepts, StemCellsInc,
and Medtronic.
Regional
Analysis:
The global regenerative medicine
market, by region, has been segmented into North America, Europe, Asia Pacific,
Latin America, and the Middle East & Africa. North America is currently
holding the largest share of the market, accounting for 44% share. It is
expected to grow significantly at a CAGR of 22.3% during the forecast period. The factors such as developments in
healthcare technology, presence of
advanced healthcare infrastructure, increasing
burden of chronic diseases, etc.
Europe has gained control over the
second-largest share of the market. It is expected to strike a high CAGR of
22.5% over the assessment period. The availability of funds coupled with the government’s support is likely to accelerate
research & development activities. This,
in turn, is prognosticated to boost the growth trajectory of the regional
regenerative medicine market in the upcoming years.
Asia Pacific is a highly lucrative market
and is expected to remain so across the review period. The rapid developments
in the healthcare sector and growing patient pool are anticipated to drive the
expansion of the regenerative medicine market in the region. It is estimated to
mark a relatively higher CAGR and emerge as the fastest growing regional market
in the foreseeable future.
Industry
News:
In November 2018, 3D.FAB, a French
additive manufacturing platform, has announced that it is working on the
development of a “living bandage” using direct additive manufacturing and 3D
bioprinting for treating damaged tissues.
In December 2018, Food and Drug
Administration has sent Genetech, a
CA-based biotechnology subsidiary of Roche, and other firms and providers
offering stem cell treatments warning letters to notify about agency's
regenerative medicine policy framework.
Browse more Pharmaceutical
Reports @ https://www.marketresearchfuture.com/categories/pharmaceutical-market-report
No comments:
Post a Comment